CN120695037A - 用于加强过热疗法的组合物和方法 - Google Patents

用于加强过热疗法的组合物和方法

Info

Publication number
CN120695037A
CN120695037A CN202510222932.9A CN202510222932A CN120695037A CN 120695037 A CN120695037 A CN 120695037A CN 202510222932 A CN202510222932 A CN 202510222932A CN 120695037 A CN120695037 A CN 120695037A
Authority
CN
China
Prior art keywords
selenium
fish oil
cells
cancer cells
yeast
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202510222932.9A
Other languages
English (en)
Chinese (zh)
Inventor
夏滉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CN120695037A publication Critical patent/CN120695037A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
CN202510222932.9A 2017-06-13 2018-06-13 用于加强过热疗法的组合物和方法 Pending CN120695037A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201762519090P 2017-06-13 2017-06-13
US62/519,090 2017-06-13
CN201880048905.2A CN111479578A (zh) 2017-06-13 2018-06-13 用于加强过热疗法的组合物和方法
PCT/US2018/037268 WO2018231938A1 (en) 2017-06-13 2018-06-13 Compositions and methods for enhancing hyperthermia therapy

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201880048905.2A Division CN111479578A (zh) 2017-06-13 2018-06-13 用于加强过热疗法的组合物和方法

Publications (1)

Publication Number Publication Date
CN120695037A true CN120695037A (zh) 2025-09-26

Family

ID=64562472

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202510222932.9A Pending CN120695037A (zh) 2017-06-13 2018-06-13 用于加强过热疗法的组合物和方法
CN201880048905.2A Pending CN111479578A (zh) 2017-06-13 2018-06-13 用于加强过热疗法的组合物和方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201880048905.2A Pending CN111479578A (zh) 2017-06-13 2018-06-13 用于加强过热疗法的组合物和方法

Country Status (9)

Country Link
US (3) US10905724B2 (enExample)
EP (1) EP3638270B1 (enExample)
JP (2) JP7336994B2 (enExample)
KR (1) KR102773006B1 (enExample)
CN (2) CN120695037A (enExample)
CA (1) CA3066742A1 (enExample)
IL (1) IL271327B2 (enExample)
TW (1) TWI823853B (enExample)
WO (1) WO2018231938A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110312439A (zh) * 2016-10-03 2019-10-08 夏滉 用于增强癌症放射治疗的组合物和方法
CA3066742A1 (en) 2017-06-13 2018-12-20 Houn Simon Hsia Compositions and methods for enhancing hyperthermia therapy
US20220175850A1 (en) * 2019-04-01 2022-06-09 Houn Simon Hsia Compositions and methods for cancer therapy
US20210393579A1 (en) * 2020-06-23 2021-12-23 Zestt Wellness Limited Anthocyanin and Quercetin Based Formulations for Improved Respiratory Health
CN115462488B (zh) * 2022-10-08 2024-01-16 河南师范大学 鞣花酸作为饲料添加剂的应用，功能性饲料及制备方法

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US988092A (en) * 1909-11-22 1911-03-28 Celfor Tool Company Drill.
US4348483A (en) 1981-01-23 1982-09-07 Universal Foods Corporation Method for the production of chromium yeast
US4569836A (en) 1981-08-27 1986-02-11 Gordon Robert T Cancer treatment by intracellular hyperthermia
CA2010511A1 (en) * 1989-03-01 1990-09-01 Roberto L. Ceriani Method of enhancing cancer therapy by administration of unsaturated fatty acids
NZ248605A (en) 1993-05-28 1994-12-22 Abbott Lab Enteral nutritional product comprising protein and fat
US20020010144A1 (en) 1994-04-29 2002-01-24 Robert Sobol Enhancing the sensitivity of tumor cells to therapies
US5976548A (en) 1994-11-08 1999-11-02 Viva America Marketing, Inc. Nutritional supplement composition and use
US6077828A (en) 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
US6440464B1 (en) 1996-06-10 2002-08-27 Viva Life Science Nutritive composition for cardiovascular health containing fish oil, garlic, rutin, capsaicin, selenium, vitamins and juice concentrates
US6197295B1 (en) 1996-09-25 2001-03-06 Viva America Marketing Corporation Dietary supplementation with, and methods for administration of yeast-derived selenium product
US5810888A (en) 1997-06-26 1998-09-22 Massachusetts Institute Of Technology Thermodynamic adaptive phased array system for activating thermosensitive liposomes in targeted drug delivery
AU5334899A (en) 1998-08-04 2000-02-28 Kosbab, John V. Nutrient and therapeutic compositions for the treatment of cancer
AU5319499A (en) * 1999-07-22 2001-02-13 Ivan L. Cameron Fatty acids to minimize cancer therapy side effects
US7569551B2 (en) 2000-02-25 2009-08-04 The University Of British Columbia Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides
JP2004533870A (ja) * 2001-03-26 2004-11-11 エレン・エイ・インコーポレーテッド 疾患組織を治療する方法及び装置
US7731648B2 (en) 2001-07-25 2010-06-08 Aduro Biotech Magnetic nanoscale particle compositions, and therapeutic methods related thereto
EP1438971A4 (en) * 2001-10-25 2005-01-12 Ttc Co Ltd IMMUNE AMPLIFIERS IN THERAPEUTIC THERAPY IN CANCER
US20040087490A1 (en) 2002-09-20 2004-05-06 Troup John P. Nutritional compositions
AU2002951833A0 (en) 2002-10-02 2002-10-24 Novogen Research Pty Ltd Compositions and therapeutic methods invloving platinum complexes
US7744930B2 (en) 2002-11-22 2010-06-29 Shaklee Corporation Compositions, methods and kits for enhancing weight loss while inhibiting loss of lean body mass
US8663679B2 (en) 2004-04-29 2014-03-04 Abbott Laboratories Compositions for improving breast health in women
US9107864B2 (en) * 2004-06-07 2015-08-18 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
US20060088574A1 (en) 2004-10-25 2006-04-27 Manning Paul B Nutritional supplements
US20070116802A1 (en) 2005-11-23 2007-05-24 Carl Germano High quality caloric composition
US8017147B2 (en) 2008-04-07 2011-09-13 Mazed Mohammad A Nutritional supplement for the prevention of cardiovascular disease, alzheimer's disease, diabetes, and regulation and reduction of blood sugar and insulin resistance
US20090110674A1 (en) 2007-10-24 2009-04-30 Loizou Nicos C Health supplement
US20110052672A1 (en) 2008-01-16 2011-03-03 Sunil Krishnan Treatments of disease or disorders using nanoparticles for focused hyperthermia to increase therapy efficacy
WO2009157759A1 (en) 2008-06-23 2009-12-30 N.V. Nutricia Nutritional composition for improving the mammalian immune system
AU2008361497B2 (en) 2008-09-04 2014-07-17 Takeshi Kobayashi Methods and kits for hyperthermia and CTLA4 inhibitory therapy
DK2344148T3 (da) 2008-09-19 2016-02-29 Nestec Sa Ernæringstilskud til forebyggelse eller moderering af knoglemarvsparalyse eller neutropæni under anti-cancerbehandling
US8257694B2 (en) 2009-05-14 2012-09-04 Product Partners, Llc Nutritional compositions for reducing oxidative damage
WO2010138902A1 (en) * 2009-05-29 2010-12-02 New Chapter Inc. Compositions and methods for modulating lipid composition
KR101275724B1 (ko) 2009-12-09 2013-06-17 한국전자통신연구원 단일 기판 집적 회로 장치 및 그 제조 방법
WO2011094579A2 (en) 2010-01-29 2011-08-04 New Chapter Inc. Mushroom compositions and methods for making and using
JP5882889B2 (ja) 2010-03-15 2016-03-09 国立大学法人 岡山大学 抗腫瘍剤
US20120010688A1 (en) 2010-07-09 2012-01-12 Lamb Karl J Implantable conductive element and method of use inhyperthermic treatment
WO2012018595A2 (en) 2010-07-26 2012-02-09 Laird Technologies, Inc. Process for the fabrication of highly electrically- conductive polymer foams with controlled compression set suitable for use in emi shielding applications
CA2806660A1 (en) * 2010-07-26 2012-02-09 Chemotherapeutics, Llc Compositions and methods for enhancing the effectiveness of systemic, hipec, ip, and related cancer treatments
US9642925B2 (en) 2010-12-07 2017-05-09 Sanford Research/USD Magnetic nanoparticle formulations, methods for making such formulations, and methods for their use
WO2012122295A2 (en) 2011-03-07 2012-09-13 Ned Biosystems, Inc. Treatment for pancreatic adenocarcinoma and other cancers of epithelial origin
CN102349699B (zh) 2011-07-04 2013-07-03 郑俊祥 一种电子烟液的制备方法
US9609457B2 (en) 2012-07-27 2017-03-28 Crexendo, Inc. Mobile application procurement and configuration options for VOIP service
KR101868675B1 (ko) 2012-10-05 2018-06-18 연세대학교 산학협력단 민감화 물질을 포함하는 온열 치료용 조성물
US9072768B2 (en) 2013-01-22 2015-07-07 Kibow Biotech, Inc. Composition and method for increasing effectiveness of radiation or chemotherapy
US9107947B2 (en) * 2013-01-31 2015-08-18 The Penn State Research Foundation Anti-cancer compositions and methods
US9889092B2 (en) * 2013-03-13 2018-02-13 The Board Of Regents Of The University Of Texas System Low density lipoprotein nanocarriers for targeted delivery of omega-3 polyunsaturated fatty acids to cancer
DE202013002760U1 (de) 2013-03-21 2014-06-23 Cc Pharma Gmbh Nahrungsergänzungsmittel zur medikationsorientierten Supplementierung
US20140294795A1 (en) * 2013-03-28 2014-10-02 Houn Simon Hsia Nutritional Composition
DK2991507T3 (da) * 2013-04-22 2019-11-04 Smartfish As Anvendelse af en sammensætning omfattende fiskeolie og juice til behandling og/eller efterbehandling af cancer
WO2015013932A1 (en) 2013-07-31 2015-02-05 Meiji Co., Ltd. Nutritional composition for inhibiting growth of tumor
WO2015021936A1 (en) 2013-08-16 2015-02-19 The University Of Hong Kong Method and compositions for treating cancer using probiotics cross-reference to related application
CN104082736A (zh) * 2014-06-13 2014-10-08 胡安然 一种调理乳腺癌的方便食品
US20170246136A1 (en) * 2014-09-24 2017-08-31 OliVentures, Inc. Pharmaceutical product, medical food or dietary supplement for preventing cancer and inflammatory diseases
CN105641000A (zh) * 2015-06-01 2016-06-08 深圳市康道生物有限公司 一种含灰树花提取物的抗肿瘤组合物及其制备方法
US10206861B2 (en) 2015-11-18 2019-02-19 Seiberg Consulting, LLC Compositions containing natural extracts and use thereof for skin and hair
CN105617358A (zh) * 2015-12-29 2016-06-01 广州市戴菊科技发展有限公司 一种具有抗肿瘤功能的医用食品及其制备方法
CN105768108A (zh) 2016-03-10 2016-07-20 福格森（武汉）生物科技股份有限公司 一种适用于肿瘤患者服用的特膳食品
JP6376186B2 (ja) 2016-08-04 2018-08-22 トヨタ自動車株式会社 サスペンションメンバ
CN110312439A (zh) 2016-10-03 2019-10-08 夏滉 用于增强癌症放射治疗的组合物和方法
CN106822560A (zh) 2017-04-07 2017-06-13 湖北工程学院 药物组合物及其制备方法
US10905725B2 (en) * 2017-06-13 2021-02-02 Houn Simon Hsia Compositions and methods for enhancing cancer chemotherapy
CA3066742A1 (en) 2017-06-13 2018-12-20 Houn Simon Hsia Compositions and methods for enhancing hyperthermia therapy
CA3066749A1 (en) 2017-06-13 2018-12-20 Houn Simon Hsia Compositions and methods for enhancing cancer radiotherapy
JP2020121479A (ja) 2019-01-30 2020-08-13 オリンパス株式会社 射出成形金型

Also Published As

Publication number Publication date
EP3638270B1 (en) 2023-10-25
EP3638270A4 (en) 2021-06-30
US11896624B2 (en) 2024-02-13
TW201902492A (zh) 2019-01-16
IL271327B2 (en) 2024-11-01
CA3066742A1 (en) 2018-12-20
KR20200078468A (ko) 2020-07-01
IL271327A (en) 2020-01-30
US10905724B2 (en) 2021-02-02
US20210154241A1 (en) 2021-05-27
US11433105B2 (en) 2022-09-06
WO2018231938A1 (en) 2018-12-20
IL271327B1 (en) 2024-07-01
JP2023105154A (ja) 2023-07-28
JP2020523375A (ja) 2020-08-06
US20220354903A1 (en) 2022-11-10
TWI823853B (zh) 2023-12-01
KR102773006B1 (ko) 2025-02-24
CN111479578A (zh) 2020-07-31
US20180353550A1 (en) 2018-12-13
EP3638270A1 (en) 2020-04-22
JP7336994B2 (ja) 2023-09-01

Similar Documents

Publication Publication Date Title
US11896624B2 (en) Compositions for enhancing hyperthermia therapy
JP5732437B2 (ja) Ｈｍｂ組成物及びその使用
PT1507554E (pt) Lactoferrina no tratamento de neoplasmas malignos e outras doenças hiperproliferativas
WO2018231937A2 (en) Compositions and methods for enhancing cancer radiotherapy
WO2018231943A2 (en) Compositions and methods for enhancing cancer chemotherapy
WO2001006983A2 (en) Fatty acids to minimize cancer therapy side effects
EP0942741A1 (en) Lectin compositions and uses thereof
US8221803B1 (en) Composition for prostate health
Prasad Antioxidants in cancer care: when and how to use them as an adjunct to standard and experimental therapies
JP2005524629A (ja) 体重、血中脂質レベルを減少させるため、並びに癌の予防および治療のためのホホバ製品
ES2342461T3 (es) Agente de estroncio no radiactivo para tratar el cancer.
HK40031147A (en) Compositions and methods for enhancing hyperthermia therapy
CN1917868B (zh) 包含l-丝氨酸、l-异亮氨酸、叶酸和痕量元素的用于治疗银屑病的组合物
CN109954052A (zh) 一种具有抗氧化活性的组合物
CN101869329B (zh) 延年益寿防癌保健饮料
CN104288432A (zh) 女性益艾柯胶囊
CN116059322A (zh) 一种治疗和预防肿瘤的口服制剂及其制备方法
WO2023017533A1 (en) A nutritional capsule of ayurvedic herbs, unani herbs, minerals, amino acids, vitamins, probiotic and nutraceuticals
TWM603762U (zh) 男性保健膠囊之構造
Griffin et al. Local Hyperthermic Treatment of Solid Tumors: Interplay Between Thermal Dose and Physiological Parameters
Prasad Synergy and Safety of Antioxidants with Cancer Drugs
Khowdiary Progress in Cancer Treatment by Orthomolecular, Food, and Water Medicine
KR20000022334A (ko) 렉틴 조성물 및 이의 용도
Issa et al. 15 General Dietary Management of
MXPA98010846A (es) Composiciones de lecitina y usos de las mismas

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination